BFC Planning’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$809K Buy
2,080
+1,611
+343% +$643K 0.03% 451
2026
Q2
$182K Sell
469
-1,406
-75% -$521K 0.01% 969
2026
Q1
$549K Sell
1,875
-51
-3% -$16.8K 0.02% 537
2025
Q4
$675K Buy
1,926
+1,351
+235% +$457K 0.03% 463
2025
Q3
$186K Sell
575
-1
-0.2% -$311 0.01% 696
2025
Q2
$224K Buy
576
+11
+2% +$4.42K 0.02% 597
2025
Q1
$246K Buy
565
+18
+3% +$7.23K 0.02% 531
2024
Q4
$202K Sell
547
-57
-9% -$23.9K 0.02% 612
2024
Q3
$314K Buy
+604
New +$323K 0.03% 455

Other funds holding ELV

BFC Planning's ELV Position: Q3 2026 in Review

BFC Planning increased its Elevance Health (ELV) stake by 343% in Q3 2026, buying an estimated $643K and bringing the position to 2,080 shares worth $809K. The position accounts for 0.03% of the portfolio, ranked #451.

BFC Planning first reported a position in ELV in Q3 2024 and has held it in 9 quarters since. 1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • BFC Planning held 2,080 shares of Elevance Health worth $809K as of Q3 2026.
  • BFC Planning bought 1,611 Elevance Health shares in Q3 2026, an estimated $643K.
  • Elevance Health made up 0.03% of BFC Planning's portfolio in Q3 2026, its #451 holding.
  • BFC Planning first reported a position in Elevance Health in Q3 2024 and has held it in 9 quarters since.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.